Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France.
Fiche publication
Date publication
mai 2019
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
Tous les auteurs :
Botsen D, Lepoix E, Mazza C, Brasseur M, Grange A, Slimano F, Bouché O
Lien Pubmed
Résumé
This study was undertaken to assess the previously unevaluated safety and feasibility of oxaliplatin-desensitization procedure add a French ambulatory cancer unit, which is a current topic in oncology. Our findings demonstrated that oxaliplatin-desensitization was safe and feasible in our ambulatory cancer unit. In routine practice, all these procedures are done on an inpatient basis starting at least the day before. Those results could change oncological practices in France and improve patients' quality of life and lower costs associated with inpatient administration.
Mots clés
Ambulatory, Anticancer drugs, Desensitization procedure, Safety
Référence
Support Care Cancer. 2019 May 17;: